Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the collaboration, FAMAR will undertake the production of two pharmaceutical products recently added to Lavipharm’s portfolio of analgesic pharmaceutical products, Lonarid N (paracetamol) and Lonalgal (caffeine Anhydrous).
Lead Product(s): Paracetamol,Caffeine
Therapeutic Area: Immunology Product Name: Lonarid N
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Famar
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 23, 2024